Susceptibility to Tigecycline and Linezolid Among Gram-Positive Isolates Collected in the United States as Part of the Tigecycline Evaluation and Surveillance Trial (TEST) Between 2004 and 2009DOWZICKY, Michael J.Clinical therapeutics. 2011, Vol 33, Num 12, pp 1964-1973, issn 0149-2918, 10 p.Article

In vitro activity of tigecycline and comparators against organisms associated with intra-abdominal infections collected as part of TEST (2004―2009)MAYNE, Donna; DOWZICKY, Michael J.Diagnostic microbiology and infectious disease. 2012, Vol 74, Num 2, pp 151-157, issn 0732-8893, 7 p.Article

Antimicrobial Susceptibility Among Gram-Negative Isolates Collected From Intensive Care Units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa Between 2004 and 2009 as Part of the Tigecycline Evaluation and Surveillance TrialBERTRAND, Xavier; DOWZICKY, Michael J.Clinical therapeutics. 2012, Vol 34, Num 1, pp 124-137, issn 0149-2918, 14 p.Article

In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST)NAGY, Elisabeth; DOWZICKY, Michael J.Scandinavian journal of infectious diseases. 2010, Vol 42, Num 1, pp 33-38, issn 0036-5548, 6 p.Article

Antimicrobial susceptibility among E. faecalis and E. faecium from France, Germany, Italy, Spain and the UK (T.E.S.T. Surveillance Study, 2004-2009)AZNAR, Javier; LEPE, JoseA; DOWZICKY, Michael J et al.Journal of chemotherapy (Testo stampato). 2012, Vol 24, Num 2, pp 74-80, issn 1120-009X, 7 p.Article

Changes in MIC Within a Global Collection of Acinetobacter baumannii Collected as Part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009MORFIN-OTERO, Rayo; DOWZICKY, Michael J.Clinical therapeutics. 2012, Vol 34, Num 1, pp 101-112, issn 0149-2918, 12 p.Article

In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: Tigecycline Evaluation and Surveillance Trial 2004 to 2007GARRISON, Mark W; MUTTERS, Reinier; DOWZICKY, Michael J et al.Diagnostic microbiology and infectious disease. 2009, Vol 65, Num 3, pp 288-299, issn 0732-8893, 12 p.Article

Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance TrialHALSTEAD, Diane C; ABID, Joan; DOWZICKY, Michael J et al.The Journal of infection. 2007, Vol 55, Num 1, pp 49-57, issn 0163-4453, 9 p.Article

Prevalence and regional variation in meticillin-resistant Staphylococcus aureus (MRSA) in the USA and comparative in vitro activity of tigecycline, a glycylcycline antimicrobialGOFF, Debra A; DOWZICKY, Michael J.Journal of medical microbiology. 2007, Vol 56, Num 9, pp 1189-1195, issn 0022-2615, 7 p.Article

Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobialDIPERSIO, Joseph R; DOWZICKY, Michael J.International journal of antimicrobial agents. 2007, Vol 29, Num 5, pp 518-527, issn 0924-8579, 10 p.Article

Antimicrobial susceptibility of extended-spectrum β-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobialHOBAN, Daryl J; BOUCHILLON, Samuel K; DOWZICKY, Michael J et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 4, pp 423-428, issn 0732-8893, 6 p.Article

Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococciMOET, Gary J; DOWZICKY, Michael J; JONES, Ronald N et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 3, pp 333-336, issn 0732-8893, 4 p.Article

Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobialDENYS, Gerald A; KOCH, Kim M; DOWZICKY, Michael J et al.American journal of infection control. 2007, Vol 35, Num 8, pp 521-526, issn 0196-6553, 6 p.Article

Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobialWAITES, Ken B; DUFFY, Lynn B; DOWZICKY, Michael J et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 10, pp 3479-3484, issn 0066-4804, 6 p.Article

Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST)BOUCHILLON, Sam K; IREDELL, Jonathan R; BARKHAM, Timothy et al.International journal of antimicrobial agents (Print). 2009, Vol 33, Num 2, pp 130-136, issn 0924-8579, 7 p.Article

In Vitro Activity of Tigecycline against Gram-Positive and Gram-Negative Pathogens as Evaluated by Broth Microdilution and EtestPILLAR, Chris M; DRAGHI, Deborah C; DOWZICKY, Michael J et al.Journal of clinical microbiology (Print). 2008, Vol 46, Num 9, pp 2862-2867, issn 0095-1137, 6 p.Article

Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecyclineREINERT, Ralf Rene; LOW, Donald E; ROSSI, Flavia et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 60, Num 5, pp 1018-1029, issn 0305-7453, 12 p.Article

Activity of tigecycline tested against a global collection of enterobacteriaceae, including tetracycline-resistant isolates : TigecyclineFRITSCHE, Thomas R; STRABALA, Patty A; SADER, Helio S et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 209-213, issn 0732-8893, 5 p.Article

Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia : TigecyclineFRITSCHE, Thomas R; SADER, Helio S; STILWELL, Matthew G et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 187-193, issn 0732-8893, 7 p.Article

In vitro activity of tigecycline against 3989 Gram-negative and gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004) : TigecyclineBOUCHILLON, Samuel K; HOBAN, Daryl J; JOHNSON, Brian M et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 173-179, issn 0732-8893, 7 p.Article

Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004) : TigecyclineFRITSCHE, Thomas R; SADER, Helio S; STILWELL, Matthew G et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 195-201, issn 0732-8893, 7 p.Article

In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004) : TigecyclineHOBAN, Daryl J; BOUCHILLON, Samuel K; JOHNSON, Brian M et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 215-227, issn 0732-8893, 13 p.Article

In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates : 2001 to 2002BOUCHILLON, Samuel K; HOBAN, Daryl J; JOHNSON, Brian M et al.Diagnostic microbiology and infectious disease. 2005, Vol 51, Num 4, pp 291-295, issn 0732-8893, 5 p.Article

Tigecycline activity tested against 26,474 bloodstream infection isolates : a collection from 6 continents : TigecyclineSADER, Helio S; JONES, Ronald N; STILWELL, Matthew G et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 181-186, issn 0732-8893, 6 p.Article

Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosaKARLOWSKY, James A; WEAVER, Mellany K; THORNSBERRY, Clyde et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 7, pp 3339-3343, issn 0095-1137, 5 p.Article